Satya Kalyan Pharmaceuticals Private Limited
About Satya Kalyan Pharmaceuticals Private Limited
Data last updated:
Satya Kalyan Pharmaceuticals Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74110AP2014PTC095129.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Satya Kalyan Estates & Infrastructures Private Limited. It is led by directors including Murali Krishna Vankayalapati and Kalyan Satyamani Vankayalapati.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sy. No. 127 Vemulavalasa Anandapuram Mandal, Visakhapatnam, Andhra Pradesh, India – 531163.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Satya Kalyan Pharmaceuticals has one previous CIN (Corporate Identification Number): U45209AP2014PTC095129. The current CIN is U74110AP2014PTC095129, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110AP2014PTC095129 | Current |
| U45209AP2014PTC095129 | Previous |
Contact details
Satya Kalyan Pharmaceuticals Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSy. No. 127 Vemulavalasa Anandapuram Mandal, Visakhapatnam, Andhra Pradesh, India – 531163
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Satya Kalyan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Satya Kalyan Pharmaceuticals Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Satya Kalyan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Satya Kalyan Pharmaceuticals Private Limited
Satya Kalyan Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishna Vankayalapati | Director | 22 Aug 2014 | 12 Years 2 Months | Current |
| Kalyan Satyamani Vankayalapati | Director | 22 Aug 2014 | 12 Years 2 Months | Current |
| Rajarajeswari Vankayalapati | Director | 22 Aug 2014 | 12 Years 2 Months | Current |
Auditor
Satya Kalyan Pharmaceuticals Private Limited is audited by KRISHNA REDDY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHNA REDDY & CO | FY 2023 | 005388S |
Shareholding
The shareholding of Satya Kalyan Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Satya Kalyan Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Satya Kalyan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Satya Kalyan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Satya Kalyan Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Satya Kalyan Pharmaceuticals Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Kalyan Satyamani Vankayalapati was appointed as Director on 22 Aug 2014.
Frequently asked questions
Satya Kalyan Pharmaceuticals is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 August 2014 (12+ years old) and is registered under CIN U74110AP2014PTC095129.
Satya Kalyan Pharmaceuticals has 3 current directors:
- Murali Krishna Vankayalapati - Director
- Kalyan Satyamani Vankayalapati - Director
- Rajarajeswari Vankayalapati - Director
The latest financial statements of Satya Kalyan Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Satya Kalyan Pharmaceuticals is U74110AP2014PTC095129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satya Kalyan Pharmaceuticals was incorporated on 22 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Vijayawada.
Kalyan Satyamani Vankayalapati was appointed as Director on 22 Aug 2014. Murali Krishna Vankayalapati was appointed as Director on 22 Aug 2014. Rajarajeswari Vankayalapati was appointed as Director on 22 Aug 2014.
The registered office of Satya Kalyan Pharmaceuticals is at Sy. No. 127 Vemulavalasa Anandapuram Mandal, Visakhapatnam, Andhra Pradesh, India – 531163.
Satya Kalyan Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Satya Kalyan Pharmaceuticals is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.
Yes. Satya Kalyan Pharmaceuticals was formerly known as Satya Kalyan Estates & Infrastructures Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
